Clinical Trial Update: Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer [NA]

View source ↗

Summary

A trial evaluating temsirolimus (Torisel) added to standard chemotherapy with radiation for advanced head and neck cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Head and Neck Cancer | NA | Status: WITHDRAWN